To combat IBD,
every Insight counts

{{In May, part of every Insight
purchase goes towards IBD research}}

Australia has one of the highest incidences of Inflammatory Bowel Disease (IBD) worldwide, affecting 1 in every 250 Australians, resulting in over 80,000 people. Being such a large issue that impacts so many in our community, it is clear that more investigation into the connection between IBD and the gut microbiome is vital.

We want to make a difference.

At Microba, our mission is to advance our understanding of how the gut microbiome influences our health and its potential involvement in the onset of diseases such as Crohn’s and Ulcerative colitis.

 

Developing Future Insights

“People who live with IBD often have no visible symptoms, but the conditions can prevent them from working or going out, keeping them socially isolated.”

– Leanne Raven, Associate Prof & CEO of Crohn’s & Colitis Australia

While current research indicates that these invisible diseases are increasing due to various genetic, environmental and lifestyle factors, there is now clear evidence that IBD is also linked to changes in the gut microbiome.

Microba has identified a serious need to further investigate the potential associations between the gut microbiome and the risks and causes of IBD.

We have therefore established the Future Insights IBD Research Program, in which we hope to better understand the functional differences between the gut microbiome in healthy subjects and IBD patients.

The overall aim of the Future Insights program is to uncover links between the gut microbiome and disease states, in order to assist with the development of future therapies.

IBD is currently our primary focus of the program as we embark on making the causes of these diseases more visible.

If you have IBD and you’re interested in participating or learning more about this research study, please contact us.

Inflammatory bowel disease: could your microbiome be involved?

Emerging evidence suggests the gut microbiome may play a role in triggering the onset of IBD, such as Ulcerative colitis and Crohn’s disease. READ MORE …